Evotec enters partnership with QUANTRO Therapeutics
- QUANTRO EXPLOITS INNOVATIVE FUNCTIONAL-GENETIC AND TRANSCRIPTOMIC TECHNOLOGIES TO ADDRESS ?UNDRUGGABLE? TARGETS
- EVOTEC TO PROVIDE HIT IDENTIFICATION SERVICES FOR QUANTRO?S PROPRIETARY ANTI-TUMOUR PROJECTS
- EVOTEC JOINS BOEHRINGER INGELHEIM VENTURE FUND AS SEED INVESTOR IN QUANTRO